Nesvategrast (SF0166) is a potent and selective αvβ3 antagonist; it inhibits vitronectin-mediated cell adhesion in human, rat, rabbit, and dog cell lines with IC50 values ranging from 7.6 pM to 76 nM; it reduces neovascularization in a mouse model of oxygen-induced retinopathy.